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P-type channels, a recently described form of voltage-gated 
calcium channels, are found in many central and peripheral 
neurons. In the present study, a partial cDNA clone sharing 
extensive nucleotide identity with a putative P-type voltage- 
gated calcium channel (Y, subunit was isolated from a small- 
cell lung carcinoma (SCLC) cell line. Anti-peptide antibodies 
generated to a unique acidic stretch in the IV!5546 linker 
region of the putative SCLC P-type channel reacted specif- 
ically with a SCLC fusion protein produced in bacteria and 
with a cell surface molecule in SCLC cells. Calcium currents 
in SCLC cells, measured by whole-cell patch clamp, were 
inhibited by these antibodies and by the P-type channel- 
specific toxin w-agatoxin WA. The inhibitory effects of the 
antibody and the toxin were not additive, consistent with 
their proposed action on the same type of channel. These 
results provide evidence for the expression of P-type cal- 
cium channels by SCLC cells. The expression of neuron- 
related molecules by these cells is of particular interest be- 
cause small-cell lung carcinoma is frequently associated 
with paraneoplastic disorders affecting the nervous system. 
[Key words: calcium channel cDNA, P-type calcium chan- 
nel, human small-cell lung carcinoma, polyclonal antibody, 
w-agatoxin IVA, patch clamp] 
Small-cell lung carcinoma (SCLC) is a common form of lung 
cancer in which the tumor cells express neuroendocrine-like 
properties. SCLC is frequently associated with paraneoplastic 
disorders affecting the nervous system. Of particular interest is 
the Lambert-Eaton myasthenic syndrome (LES), an autoim- 
mune disease of neuromuscular transmission that is often as- 
sociated with SCLC (Lang et al., 1983; Kim, 1986; Vincent et 
al., 1989). The target of the autoimmune reaction is thought to 
be a voltage-gated calcium channel in the presynaptic membrane 
that couples neurotransmitter release to membrane depolariza- 
tion (Kim and Neher, 1988; Peers et al., 1990). Autoantibody 
production may be triggered by the expression of a voltage- 
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gated calcium channel in SCLC cells that resembles that found 
at the presynaptic nerve terminal (Roberts et al., 1985). 
Voltage-gated calcium channels (VGCCs) regulate calcium 
influx into neuronal cells and control the calcium-dependent 
release of neurotransmitters and peptide hormones (Miller, 1987). 
It is likely that VGCCs play a similar role in SCLC cells, which 
are known to secrete a large number of ectopic hormones (Rus- 
sell et al., 1990). VGCCs are generally classified as L-, N-, P-, 
and T-type based on their electrophysiological behavior and 
distinct pharmacological sensitivities. Although P-type channels 
were originally described in Purkinje cells (Llinas et al., 1992) 
hence the name, there is now evidence for a wider distribution 
in the nervous system (Llinas et al., 1989; Hillman et al., 199 1; 
Regan et al., 199 1; Usowicz et al., 1992). P-type channels are 
resistant to both dihydropyridine (DHP) antagonists and w-con- 
otoxin GVIA (w-CgTx-GVIA), but are blocked by toxins iso- 
lated from venom of the funnel web spider. These toxins include 
a small polyamine toxin, funnel toxin @TX) (Llinls et al., 1989, 
1992) and a peptide toxin, w-agatoxin IVA (w-Aga-IVA) (Mintz 
et al., 1992a,b). The release of the neurotransmitter glutamate 
at mammalian presynaptic nerve terminals is blocked by w-Aga- 
IVA, implicating P-type channels (Turner et al., 1992). Fur- 
thermore, the mammalian neuromuscular junction contains 
P-type channels as indicated by the inhibition of presynaptic 
calcium flux by FTX (Uchitel et al., 1992). The evoked release 
of acetylcholine at the mammalian neuromuscular junction is 
likewise blocked by FTX (Uchitel et al., 1992) and w-Aga-IVA 
(Kim et al., 1993). Finally, P-type channels are sensitive to a 
novel conotoxin, w-CgTx-MVIIC, that acts on mammalian pre- 
synaptic nerve terminals (Hillyard et al., 1992). 
The 01, subunit of VGCCs forms the pore of the channel and 
is evolutionarily related to voltage-gated Na+ and K+ channels. 
Six classes of calcium channel cyI subunits have now been iden- 
tified by molecular cloning (Snutch and Reiner, 1992). Three 
of these classes are believed to be L-type channels, including 
those isolated from skeletal and cardiac muscle and brain (Tan- 
abe et al., 1987; Mikami et al., 1989; Hui et al., 1991). A fourth 
class includes a presumptive P-type o(, subunit, called B 1, which 
was isolated from rabbit brain and expressed in Xenopus oocytes 
(Mori et al., 199 1). It resembles P-type channels in its apparent 
tissue distribution; however, its single-channel properties and 
pharmacology are not entirely consistent with that of P-type 
channels described in Purkinje cells (Sather et al., 1993). A fifth 
class of a, subunits is sensitive to w-CgTx-GVIA and therefore 
corresponds to N-type channels (Dubel et al., 1992; Williams 
et al., 1992). Finally, the most recently described class has char- 
acteristics of a low-voltage-activated (T-type) calcium channel 
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(Soong et al., 1993). The functional properties of another re- 
cently cloned calcium channel have not yet been described (Nii- 
dome et al., 1992), but the channel appears to be most closely 
related to a calcium channel isolated from a marine ray that 
expresses novel kinetic and pharmacological characteristics (El- 
liner et al., 1993). 
There is considerable evidence that SCLC cells express volt- 
age-gated calcium channels. Depolarization-induced Ca2+ flux 
in SCLC cells is inhibited by DHP antagonists and w-CgTx- 
GVIA, thereby suggesting the presence of L- and N-type chan- 
nels (De Aizpurua et al., 1988; Sher et al., 1990). In addition, 
the whole-cell patch-clamp technique has been used to dem- 
onstrate the presence of DHP-sensitive L-type channels (Pan- 
crazio et al., 1989; Pancrazio et al., 1992). In the present study 
we identify a presumptive P-type VGCC transcript in SCLC 
cells. A polyclonal antiserum was produced to a peptide encoded 
by a partial cDNA clone. The purified antibodies inhibited cal- 
cium currents expressed in SCLC cells, as did the P-type chan- 
nel-specific toxin w-Aga-IVA. These results provide evidence 
for the expression of a P-type calcium channel in SCLC cells. 
Materials and Methods 
Cell culture 
H 146, H209, and H345 human small-cell lung carcinoma cells (Gazdar 
et al., 1980) were obtained from American Type Culture Collection and 
cultured in RPM1 1640 medium (GIBCO/Bethesda Research Labs) sup- 
plemented with 10% fetal bovine serum (GIBCO/Bethesda Research 
Labs). H146 cells were chosen as the experimental model due to their 
robust calcium currents (Pancrazio et al., 1989); normal untreated H146 
cells demonstrate maximal Ic, ranging from 10 pA to 375 pA [mean of 
115.8 f 3.9 (?SEM) pA, n = 303 cells]. The C2 mouse muscle cell line 
was cultured as described (Silberstein et al., 1982) and fused myotubes 
were used for the isolation of RNA. 
Isolation of cDNA clones by PCR 
Purification of RNA. PolyA+ RNA was isolated from cultured cells as 
previously described (Bradley et al., 1988). Briefly, cells were pelleted 
bv centrifuzation and homogenized in the presence of 2% SDS. After 
incubation-with proteinase K (Boehringer Mannheim), the cell lysate 
was batch adsorbed to oligo(dT) cellulose (Collaborative Research), and 
polyA+ RNA was eluted in salt-free buffer. 
First-strand cDNA synthesis. PolyA+ RNA, 10 pg, was reverse tran- 
scribed in a 100 ~1 reaction volume containing 10 U/PI Moloney murine 
leukemia viral reverse transcriptase (GIBCO/Bethesda Research Labs), 
10 ng/pl random hexamers (Pharmacia), 0.5 mM dNTPs (Pharmacia), 
100 rg/ml bovine serum albumin (GIBCO/Bethesda Research Labs), 
and 1 U/w1 RNasin (Promega) in 50 mM Tris-HCl, pH 8.3,75 mM KCl, 
10 mM dithiothreitol (DTT), and 3 mM MgCl,. The mixture was in- 
cubated for 5 min at room temperature (to extend the hexamers) fol- 
lowed by 1 hr at 37°C. The cDNA product was isolated by phenol: 
chloroform extraction and ethanol precipitation for use in PCR. 
PCR. Aliquots of cDNA, equivalent to l/l0 of the above reaction, 
were incubated in a 100 r.d reaction volume containing 10 mM Tris- 
HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl,, 0.001% gelatin, 200 PM of 
each dNTP, 0.2 PM of each primer, and 2.5 U of DNA polymerase 
(amplitaq, Perkin-Elmer), and overlaid with 100 pl of mineral oil (Sig- 
ma). PCR was performed on an automated thermalcycler (Perkin-Elmer 
Cetus) that was programmed to repeat the following cycle 30 times: 60 
set at 94”C, 60 set at 60°C and then 120 + 2 set/cycle at 72°C. 
PCR primers. Primers were designed from regions that are perfectly 
conserved between rabbit skeletal (Tanabe et al., 1987) and cardiac 
muscle (Mikami et al., 1989) L-type calcium channels. The sequence 
of the upstream primer was 5’-gtgggaattcatcaagtccttccaggccct-3’, and the 
downstream primer, 5’-caggggatccaagttgtccatgatgacagc-3’. Restriction 
sites (italic) were included near the 5’ ends of the primers to facilitate 
directional subcloning: EcoRl in the upstream primer and BamHl in 
the downstream primer. The PCR primers were synthesized locally and 
crude trityl-on oligonucleotides were eluted from the glass support col- 
umns with ammonium hydroxide and purified on Nensorb (DuPont) 
prep columns. 
Cloning. The products of the PCR reaction were directionally cloned 
into the Bluescript KS vector (Stratagene). Initially, one-fifth of each 
PCR reaction was analyzed by electrophoresis on 3% Nuseive/ 1% Seak- 
em agarose (FMC) gels. For subcloning, the remaining reaction product 
was purified by phenol extraction and ethanol precipitation, digested 
with EcoRl and BamH 1, and isolated as a band from a low-melt Nu- 
seive/agarose gel. The vector was also digested with EcoR 1 and BamH 1 
and isolated on a low-melt agarose gel. The PCR product and vector 
were ligated and used to transform XL- 1 Blue bacteria. Plasmid DNA 
was prepared from individual colonies and sequenced by the dideox- 
ynucleotide chain termination procedure from double-stranded DNA 
templates. Sequence comparison was performed using the Intelligenetics 
and the Genetics Computer Group on-line software. 
Northern blot analysis 
Total RNA was isolated from cultured cells by the guanidinium iso- 
thiocyanate/phenol procedure (Chomczynski and Sacchi, 1987). Total 
RNA, 50 pg, was run in each lane of an 0.8% agarose-formaldehyde 
denaturing gel and electrophoretically transferred to Genescreen nylon 
membrane (DuPont). The membranes were UV cross-linked and then 
prehybridized in 0.75 M NaCl, 0.05 M NaH,PO,, 5 mM EDTA, 0.1% 
Ficoll, 0.1% polyvinylpyrrolidone, 0.1% bovine serum albumin (BSA) 
(Pentax Fraction V), 50% formamide, 1% SDS, 10% dextran sulfate, 
and 100 pg/ml salmon sperm DNA at 45°C for 20 hr. Hybridization 
with ‘*P-labeled riboprobes was carried out under the same conditions 
as the prehybridization. The membranes were then washed in 15 mM 
NaCl. 1 mM NaH,PO,. 0.1 mM EDTA. and 0.1% SDS at 65°C and 
treated with 1 &ml RNase A for 15 min in 0.3 M NaCl and 30 mM 
Na,citrate to decrease background interference. Autoradiography was 
carried out at - 70°C with an intensifying screen. Hybridization with a 
control riboprobe for human p-actin was used to demonstrate that sim- 
ilar amounts of undegraded RNA were probed in each lane (not shown). 
Production and characterization of polyclonal antibodies 
Peptide design and antibody isolation. A peptide, NH,-IDVEDEDS- 
DEDEFC-CO,, corresponding to a unique nucleotide stretch (residues 
79-l 18) in clone SCLC-P, was synthesized, conjugated to keyhole limpet 
hemocyanin, and used for the production of antiserum in rabbits (Mac- 
romolecular Resources, Fort Collins, CO). Peptide-specific antibody was 
purified by affinity chromatography. Peptide, 25 mg, was solubilized in 
DMSO and coupled to 2 ml of Affi Gel- 10 resin (Bio-Rad). Antiserum 
was heat inactivated and batch absorbed to peptide resin equilibrated 
in 137 mM NaCI, 2.7 mM KCl, 4.3 mM Na,HPO,, and 1.4 mM KH,PO, 
(PBS). Antibody was eluted in 0.2 M glycine, pH 2.5, immediately neu- 
tralized with 1.5 M Tris, pH 8.8, and dialyzed against PBS. The affinity- 
purified antibody was used for Western blotting and immunofluores- 
cence and in patch-clamp experiments. 
Subcloning the SCLC-P clone into a bacterial expression vector. The 
SCLC-P clone was subcloned into the BamH 1 site of the bacterial ex- 
pression vector pGEX-3X (Pharmacia) as follows. SCLC-P cDNA gen- 
erated by PCR was restriction digested at the 3’ end with Mbol at 
nucleotide 17, generating sticky ends that are compatible with those 
generated by BamH 1, and at the 5’ end with BamH 1 at the site engi- 
neered into the PCR primer. The restricted SCLC-P DNA was ligated 
to the BamH 1 -digested vector and the products were used to transform 
XL-I Blue bacteria. Recombinants containing the SCLC-P insert in the 
sense orientation were selected by restriction analysis and used for the 
expression of a fusion protein. 
Expression of the SCLC-P fusion protein. Transformed bacteria con- 
taining either the SCLC-P recombinant vector or control vector (without 
insert) were grown overnight at 37°C in LB medium containing ampi- 
cillin. Cultures were diluted 1: 10 in fresh medium and grown for 1 hr 
before expression of the glutathione-S-transferase (GST) fusion protein 
was induced by the addition of IPTG, 0.1 mM final concentration. After 
5 hr, the cells were harvested by centrifugation and solubilized in gel 
sample buffer (0.125 M Tris-HCl, pH 7.4, 4% SDS, 200 mM DTT, 20% 
glycerol, bromphenol blue). Total-cell lysates were analyzed by electro- 
nhoresis on 12% SDS-PAGE gels. Some lanes of the ael were cut out 
for visualization of protein by-staining with Coomassye brilliant blue. 
Duplicate lanes from the gel were electrophoretically transferred to ni- 
trocellulose paper for Western blotting. 
Western blotting. Duplicate nitrocellulose strips were incubated in 10 
mM Tris-HCl, pH 7.4,500 mM NaCI, 0.05% Tween-20,0.1% cold water 
fish gelatin, 0.08% BSA, and 6% normal goat serum at room temperature 
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RabBrain-P IGMQVFGNIG IDMEDEDSDE DEFQITEHNN FRTFFQALM 
HumBrain-N IGMQVFGNIA LD........ DDTSINRHNN FRTFLQALM 
RatBrain-T IGMQVFGNIK LD........ EESHINRHNN FRSFFGSLM 
RabSkeletal IGMQMFGKIA LV........ DGTQINRNNN FQTFPQAVL 
RabCardiac IGMQVFGKIA LN........ DTTEINRNNN FQTFPQAVL 
RatBrain-L IGMQMFGKVA MR........ DNNQINRNNN FQTFPQAVL 
Figure 1. Sequence of SCLC-P Ca2+ channel 01~ subunit cDNA clone. The nucleotide sequence (4) and the deduced amino acid sequence (B) of 
the SCLC-P clone (ZZumSCLC-P) are compared with the rabbit brain (P-type) Caz+ channel sequence (RubBrain-P) (Mori et al., 1991). Residues 
that are identical are connected by dashes. The numbers at ends of each line are the nucleotide or amino acid residue numbers. The putative 
transmembrane segments (II’S5 and Zl’S6) of the fourth homology domain are indicated by lines above the sequence. A peptide corresponding to 
the underlined residues in the SCLC-P amino acid sequence (B) was used for the production of polyclonal antibodies. C, A comparison of the 
deduced amino acid sequences of six classes of Ca*+ channels with that of the SCLC-P clone in the vicinity of a unique acidic region. The sequences 
shown are the SCLC-P clone described in this manuscript (ZZumSCLC-P), the rabbit brain P-type Ca*+ channel (RubBruin-P) (Mori et al., 1991), 
the human brain N-type Ca2+ channel (HumBrain-&‘) (Williams et al., 1992), the rat brain T-type Caz+ channel (RatBrain-T) (Soong et al., 1993), 
the rabbit skeletal muscle L-type Cal+ channel (RubSkeletal) (Tanabe et al., 1987) the rabbit cardiac muscle L-type Ca*+ channel (RabCardiac) 
(Mikami et al., 1989) and the rat brain L-type Ca 2+ channel (RatBrain-L) (Hui et al,, 199 1). 
as follows: (1) 1 hr without antibody to block nonspecific binding sites, 
(2) 8 hr with 5 nM affinity-purified anti-peptide antibody, and (3) 1 hr 
with alkaline phosphatase-conjugated goat anti-rabbit secondary anti- 
body (1: 10,000) (Jackson Immunoresearch). The strips were developed 
using 5-bromo-4-chloro-3-indolyl phosphate and nitro blue tetrazolium 
(Sigma). In some cases the anti-peptide antibody used in step 2 was 
preincubated for 1 hr with 26 PM peptide to determine nonspecific 
binding. 
Zmmunofluorescence. Immunofluorescence was performed on cells in 
suspension at room temperature. The cells were pelleted at 6000 rpm 
for 1 min and the supematant was aspirated for solution changes. Cells 
were washed three times in PBS and fixed in 1% paraformaldehyde 
containing 150 mM lysine for 30 min. All subsequent incubations and 
washes were in PBS, 0.1% cold water fish gelatin, 0.08% BSA, and 6% 
normal goat serum. Cells were incubation for 30 min in the absence of 
antibody and then for 70 min with 100 nM affinity-purified anti-peptide 
antibody. In some cases the anti-peptide antibody was preincubated for 
1 hr with 26 I.LM peptide to determine nonspecific binding. The cells 
were washed three times and incubated with fluorescein-conjugatedgoat 
anti-rabbit secondary antibody (1:200) (Jackson Immunoresearch) for 
50 min. After three additional washes, the cells were pelleted, resus- 
pended in 30% glycerol, 12% Mowiol (Calbiochem), 120 mM Tris, pH 
8.5, and mounted on glass slides. Photographs were taken on a Zeiss 
microscope using a 63 x oil-immersion objective. 
Incubation of HI46 cells with antibodies 
Prior to applying the antibodies to the H 146 cells, both control (rabbit 
IgG, Sigma) and anti-peptide antibodies were dialyzed against RPM1 
for 48 hr with one dialysate change at 24 hr. Antibodies were then 
diluted into the cancer cell suspension to the desired concentration (0.02 
or 0.04 mg/ml IgG) and allowed to react with the cells for 1 hr at 37°C. 
To affix the cells for patch-clamp recordings, the cell suspension was 
plated onto poly-L-lysine-coated (Sigma) coverslips and returned to 
37°C for 1 hr. Thus, the cells were exposed to the antibodies for a total 
of 2 hr prior to patch-clamp analysis. Experiments were carried out 
using cells that had been subcultured the previous day. For a given 
experiment, control and treatment cells were always taken from the 
same culture flask. 
Patch-clamp recordings 
Standard patch-clamp protocols were used to obtain whole-cell record- 
ings of Z,, and Zc, (Hamill et al., 1981). Patch-clamp pipettes were 
fashioned from borosilicate glass (Kimax- 1, Kimble Products, Vine- 
land, NJ) and the tips coated with Sylgard (Dow Coming, Midland, MI) 
to reduce pipette capacitance. Pipettes typically had resistances of -2 
MR. Prior to eliciting voltage protocols, cells were maintained at the 
holding potential for 1 min. Voltage clamping was performed with an 
L/M-EPC-7 patch-clamp amplifier (List Medical, Darmstadt, Germa- 
ny). Signals were filtered through an b-pole low-pass Bessel filter (Fre- 
quency Devices, Haverhill, MA) with a cutoff frequency of 3 kHz. Data 
acquisition and analysis were accomplished with FRUMP software (Axon 
Instruments, Foster City, CA) using a PC-compatible 486 computer and 
Lab Master DMA TL- 1 interface (Axon Instruments). From the holding 
potential, 7-16 consecutive depolarizations ranging from -60 mV to 
+90 mV in 10 mV increments were applied to each cell. Pulses were 
of 350 msec duration at a frequency of 0.2 Hz and sampled at 2.5 kHz. 
A P/4 procedure (Armstrong and Bezanilla, 1977) was used to eliminate 
capacitative and leak currents. 
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Figure 2. Autoradiogram of a Northern blot of RNA hybridized to an 
SCLC Ca*+ channel 01~ subunit riboprobe. An SCLC-P riboprobe was 
hybridized with total RNA (50 &lane) isolated from SCLC (lane I) or 
muscle (lane 2) cell lines. Autoradiography was for 3 d at -70°C. An 
RNA ladder (GIBCO/Bethesda Research Labs) was used for size mark- 
ers (in kilobases). 
For all recordings, the patch-clamp pipettes were filled with 120 mM 
CsCl, 20 mM TEA-Cl, 11 mM EGTA-NaOH, 1 mM CaCl,, 2 mM MgCl,, 
and 10 mM HEPES-NaOH, pH 7.2. The external recording solution 
consisted of 130 mM NaCl, 5 mM KCl, 10 mM CaCl,, and 10 mM 
HEPES-NaOH. oH 7.2. For all exneriments in which the cells were 
exposed to w&A-IVA, 10 mM BaCl, was substituted for the CaCl, in 
the bath solution. w-CgTx-GVIA (Sigma) and w-Aga-IVA were stored 
frozen at -20°C as stocks after reconstitution. Stock solutions were 
diluted into the recording chamber to achieve the desired final concen- 
tration of drug (bath volumes were 1 or 2 ml). Nifedipine (Sigma) was 
dissolved in DMSO and stored at 4°C. Before each experiment, the 
nifedinine stock was diluted to working stocks with distilled H,O. All 
nifedipine experiments were performed% a darkened environment. To 
avoid time-dependent effects, cells were pretreated for 10 min with 
vehicle or drug and recordings were made 1 min after establishment of 
a whole-cell patch. 
I,, was taken as the peak transient component occurring within the 
first 5 msec. Peak Zc, was measured as the maximum current between 
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Figure 3. SDS-PAGE gel and Western blots of fusion-protein bacterial 
lysates using anti-peptide antibody. Total cell lysates from bacteria 
transformed with control fusion protein vector (lane 1) or the SCLC-P 
recombinant fusion protein vector (lane 2) were electrophoresed on an 
SDS-PAGE gel and the gel was stained for protein (left). The sizes of 
the molecular weinht markers (lane 3) (GIBCO/Bethesda Research Labs) , . 
are indicated (in kilodaltons). Duplicate lanes were transferred to ni- 
trocellulose strips for blotting with an anti-peptide antibody in the ab- 
sence (middle) or presence (rzght) of competing peptide. 
measured as the current at the end of the 350 msec pulse. To avoid 
discrepancies due to cell size, current valtres for each cell were divided 
by the capacitance of that cell and currents were reported as current 
density (pA/pF). Experiments were done in pairs; each data set was 
normalized against its own control and results were pooled across ex- 
periments to obtain mean f SEM. Student’s t test was used for statistical 
analyses; p < 0.05 was considered significant. 
Results 
Isolation and characterization of SCLC calcium channel 
cDNA clones 
Partial cDNA clones corresponding to putative Ca2+ channel 01, 
subunits were isolated from human H 146 SCLC cells using the 
polymerase chain reaction (PCR). The sequences of the SCLC 
clones obtained were compared to the published sequences of 
Caz+ channels. One of these clones, SCLC-P (345 bp), is most 
highly homologous to the presumptive P-type Caz+ channels 
isolated from rabbit (called B 1; Mori et al., 199 1) and rat brain 
(called rbA; Starr et al., 199 1). The degree of homology to the 
Bl transcript is 89.7% at the nucleotidelevel (Fig. 1A) and 98.2% 
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Figure 4. Immunofluorescence stain- 
ing of SCLC cells with anti-peptide an- 
tibody. HI46 SCLC cells were stained 
with anti-peptide antibody in the ab- 
sence (a) or presence (b) of competing 
peptide. 
at the amino acid level (Fig. lB), whereas homology to the 
skeletal muscle L-type channel (Tanabe et al., 1987) is 63.1% 
and 54.7%, respectively (not shown). The high degree of ho- 
mology suggests that this clone represents the human homolog 
of the rabbit brain channel described by Mori et al., and not a 
novel form of calcium channel. This clone contains a small 
region of particular interest: a short stretch (24 nucleotides) 
coding for very acidic amino acids that appears to be unique to 
this type of calcium channel (Fig. 1 C). This acidic region is not 
found in any of the three classes of L-type channels (Tanabe et 
al., 1987; Mikami et al., 1989; Hui et al., 1991; Snutch et al., 
1991) or in the presumptive N-type channels that have been 
described to date (Dubel et al., 1992; Williams et al., 1992), nor 
is this sequence found in a member of the low-voltage-activated 
(T-type) calcium channel family recently cloned from rat brain 
(Soong et al., 1993). It is also not present in a novel channel 
from rabbit brain (Niidome et al., 1992) (not shown). 
Northern analysis was used to detect expression of mRNA 
transcripts corresponding to the SCLC-P clone (Fig. 2). The 
SCLC-P clone hybridized to a single mRNA of approximately 
9.0 kb from the H146 SCLC cell line (lane 1) but not to any 
mRNA isolated from a muscle cell line (lane 2) that was used 
as a negative control. An L-type calcium channel probe detected 
a 6.5 kb band in muscle RNA, thereby demonstrating the in- 
tegrity of the RNA (not shown). The 9.0 kb message in SCLC 
is approximately the same size as that reported for the Bl cal- 
cium channel transcript in rabbit brain (Mori et al., 1991). To 
determine if expression of this Ca*+ channel mRNA is common 
to other SCLC cell lines, total RNA was prepared from H345 
and H209 cells. Clone SCLC-P hybridized to a single 9.0 kb 
mRNA from these cells as well (not shown). 
Production and characterization of polyclonal anti-peptide 
antibodies 
As described above, we have found evidence for the presence 
of the transcript for a presumptive P-type calcium channel in 
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human SCLC cells. To study the expression of the calcium chan- 
nel protein, antibodies were raised to a unique acidic peptide, 
IDVEDEDSDEDEF, corresponding to a cDNA sequence in the 
IV S5-S6 linker region of SCLC-P (Fig. 1B). This peptide has 
not been found in any of the other classes of calcium channels 
cloned to date (Fig. 1C) and is predicted to be located on the 
extracellular side of the membrane. 
To determine the specificity of the antibodies, they were used 
for western blotting of the SCLC-P clone expressed as a fusion 
protein with GST (glutathione-S-transferase). Total cell lysates 
‘from bacterial cell cultures were analyzed by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (Fig. 3). 
The 27,500 Da GST protein was the major band seen in lysates 
from cells transformed with control vector (no SCLC-P insert) 
and induced with IPTG (Fig. 3, left, lane 1). When cells were 
transformed with recombinant vector containing the SCLC-P 
clone insert, a major inducible protein band of approximately 
40,000 Da was seen, which corresponds to the predicted size of 
the fusion protein (Fig. 3, left, lane 2). Western blot analysis 
revealed that the antibody bound to the 40,000 Da SCLC-P- 
GST fusion protein band from recombinant cell lysates (Fig. 3, 
middle, lane 2). Some smaller bands were also seen that are 
believed to be degradation products of the fusion protein. How- 
ever, the antibody did not bind to any of the proteins in the 
control cellular lysate (Fig. 3, middle, lane 1). In addition, bind- 
ing to the fusion protein was inhibited by preincubation of an- 
tibody with peptide (Fig. 3, right, lane 2). Thus, the anti-peptide 
antibody bound specifically to the SCLC-P portion of the fusion 
protein. 
We were unable to detect the SCLC calcium channel protein, 
or any other protein, by immunoblotting total cell lysates from 
H 146 cells. This result is not surprising because the channel is 
likely to make up too small a portion of the total cellular protein 
to be detected by this method. Therefore, at least partial puri- 
fication ofthe protein may be necessary before it can be detected. 
Immunofluorescence was performed on nonpermeabilized 
SCLC cells to determine if the anti-peptide antibody recognized 
a native molecule on the cell surface. Antibody bound to the 
surface of H 146 cells (Fig. 4~). Binding was inhibited by prein- 
cubation of antibody with peptide (Fig. 4b). Similar results were 
obtained with the H345 and H209 SCLC cell lines (not shown). 
Very low background levels of binding of control rabbit IgG 
were detected, but binding was not blocked by preincubation 
with peptide (not shown). These results indicate that the anti- 
peptide antibody recognizes a protein that is expressed on the 
surface of SCLC cells and are consistent with the proposed lo- 
calization of the antigen (VGCC) to the cell membrane. 
Inhibition of calcium currents by anti-peptide antibodies 
The anti-peptide antibodies are predicted to bind near the ex- 
tracellular entrance to the pore of the calcium channel; thus, it 
is possible that binding may inhibit channel activity. Inhibition 
ofcalcium currents in H 146 cells was examined using the whole- 
cell patch-clamp technique. Inward currents from H146 cells 
were elicited at a range of potentials from a holding potential 
of -80 mV. In cells exposed to 10 mM [Ca2+],, the whole-cell 
currents were characterized by an initial transient component 
consisting of current carried by sodium (INa) and a second long- 
lasting component, the calcium current (I,,) (see Figs. 54, 6A). 
H 146 cells were treated with control or anti-peptide antibodies 
(0.02 mg/ml IgG) for 2 hr prior to patch-clamp analysis. Both 
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Figure 5. Inhibition of calcium currents in H 146 SCLC cells by anti- 
peptide antibodies. A, Representative current recordings from a cell 
treated with control antibodies and a cell treated with anti-peptide an- 
tibodies (0.02 mg/ml IgG) for 2 hr. Zc, was elicited with a depolarization 
to + 10 mV from a holding potential of -80 mV in 10 mM [Ca2+],. B, 
Current-voltage relationships for cells treated with control antibodies 
and cells treated with anti-peptide antibodies (0.02 ma/ml InG). Curves - -I 
are the average of 33 control cells and 25 treatment cells. Error bars are 
SEM. Peak I,, is nlotted. C, Summarv of data obtained from the cells 
described in &. Bar graphs show the effect of the anti-peptide antibodies 
on peak (maxima1 1,, at the beginning of the depolarization) and plateau 
Zca (measured as the maximal Zc, at the end of the stimulus). *, p < 
0.05. 
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Figure 6. Inhibition of calcium currents in H 146 SCLC cells by w-a- 
gatoxin IVA. A, Representative current recordings from a control cell 
(untreated) and a cell pretreated for 10 min with 50 nM w-Alga-WA. I,-= 
was elicited with a depolarization to + 10 mV from a holding potential 
of - 80 mV. B, Current-voltage relationships for control cells (untreated) 
and for cells treated with 50 nM w-Alga-WA. Curves are the average of 
35 control cells and 32 treatment cells. Error bars are SEM. Peak Zc, is 
plotted. Note that peak I,, is shifted 10 mV compared to Figure 5 due 
to the change in the charge carrier from calcium to barium. C, Summary 
of the data obtained from the cells described in B. Bar graphs show the 
effect of the toxin on peak and plateau Zc,. *, p < 0.025. 
plateau Z,, (measured at the end of the 350 msec depolarization) 
were studied because other reports suggest that P-type channels 
do not inactivate with long depolarization (Llinas et al., 1989; 
Regan et al., 199 1; Usowicz et al., 1992). Peak Zc,, which was 
maximal at + 10 mV, was reduced by 20 -t 6% (mean t SEM, 
y2 = 25 cells, p < 0.05) in cells treated with anti-peptide anti- 
bodies relative to cells treated with control antibodies (Fig. 5). 
The anti-peptide antibodies did not inhibit peak Zc= evoked at 
potentials below + 10 mV, although peak I,, measured from 
+ 10 mV to + 30 mV was similarly reduced by approximately 
20%. The plateau I,, measured during depolarization to + 10 
mV was likewise diminished by 19 ? 7% (n = 25 cells, p < 
0.05) after exposure to the anti-peptide antibodies (Fig. 5C). 
Increasing the concentration of antibody to 0.04 mg/ml did not 
increase the amount of reduction observed; therefore, a con- 
centration of 0.02 mg/ml IgG was used for all subsequent ex- 
periments. 
To confirm that the antibodies reduce I,, by specifically in- 
hibiting the action of calcium channels, we assessed antibody 
effects on ZNa in the same cells used for I,, analyses. Accordingly, 
cells that had been incubated in the anti-peptide antibodies 
exhibited a maximal Z,, of 54.3 * 5.5 pA/pF (n = 25), which 
was not significantly different from the control Z,, of 6 1.4 f 5.1 
pA/pF (n = 33, p > 0.1) (not shown). 
If the antibodies inhibit a P-type calcium channel in H146 
cells, then it would be expected that (1) I,, should be sensitive 
to w-Aga-IVA, (2) the inhibitory effect of the antibodies and the 
w-Aga-IVA on the Zc, should not be additive, and (3) the an- 
tibodies should reduce the I,, in the presence of a DHP antag- 
onist and w-CgTx-GVIA. To test these hypotheses, we per- 
formed the following experiments. 
To assess the effect of w-Aga-IVA on calcium channel activity, 
10 mM BaCl, was substituted for the CaCl, in the bath solution. 
This permitted comparison with previous reports on the effects 
ofw-Aga-IVA (Regan et al., 1991; Mintz et al., 1992b). Treat- 
ment of H146 cells with 50 nM w-Aga-IVA for 10 min reduced 
the magnitude of the peak I,, by 28 * 6% (n = 29 cells, p < 
0.005) (Fig. 6). Similarly, the plateau phase of the I,, was re- 
duced by 26 + 7% (n = 29, p < 0.025) (Fig. 6C). The shape of 
the current-voltage curves and the reversal potential were un- 
changed after incubation with toxin; only the magnitudes of the 
currents were reduced. In addition, ZNa was not significantly 
affected by the w-Aga-IVA (not shown). 
The effect of w-Aga-IVA was also assessed on H 146 cells that 
were pretreated for 2 hr with anti-peptide antibodies and sub- 
sequently exposed to 50 nM w-Aga-IVA (Fig. 7). Peak Zc, was 
reduced by 32 f 8% (n = 18 cells, p < 0.05); a reduction similar 
to that observed when the toxin was applied alone. Although it 
appears that the toxin and antibody combination may inhibit 
I,, slightly more than either agent alone, the difference is not 
statistically significant. These results support the hypothesis that 
the antibody and the toxin act on the same type of calcium 
channel in H146 cells. 
H146 cells are known to express I,, that is sensitive to both 
DHP antagonists and w-CgTx-GVIA (Viglione et al., 1993). 
P-type calcium channels, however, are insensitive to these agents 
(Mintz et al., 1992b). Therefore, we examined whether the an- 
tibodies were effective at reducing the I,, that remained after 
their application. In the absence of antibody, 10 NM nifedipine 
and 1 FM w-CgTx-GVIA inhibit 40 + 6% of peak I,, and 47 -t 
6% of plateau I,, (Fig. 7). With these additional agents in the 
recording solution, the anti-peptide antibodies reduced the peak 
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Figure 7. Inhibition of calcium cur- 
rents in H146 SCLC cells by combi- 
nations of anti-peptide antibodies and 
toxins or DHP. Prior to recording Ic,, 
H 146 cells were treated as follows: Con- 
trol, 0.02 mg/ml control IgG for 2 hr; 
Ab On/y, 0.02 mg/ml anti-peptide an- 
tibody for 2 hr; Aga- I VA, 50 nM w-Aga- 
IVA for 10 min; Ab + Agu-IVA, 0.02 
mg/ml anti-peptide antibodies for 2 hr 
and then 50 nM w-Aga-IVA for 10 min; 
DHP + CgTx, 10 PM nifedipine plus 1 
PM w-CgTx-GVIA for 15 min; Ab + 
DHP + CgTx, 0.02 mg/ml anti-peptide 
antibodies for 2 hr and then 10 PM ni- 
fedipine and 1 PM w-CgTx-GVIA for 
15 min. All reductions are significant 
(p < 0.05). The data for effect of the . . 0 25 50 75 100 125 antibodies or o-Aga-IVA alone are du- 
plicated from Figures 5 and 6 for com- 
% of Control parison purposes. 
and plateau Z,., by 66 k 10% (n = 16 cells) and 85 * 9% (n = 
16 cells), respectively (Fig. 7). Notably, in the presence of ni- 
fedipine and w-CgTx-GVIA, the plateau I,, (where the nifedi- 
pine is most effective) was reduced to a greater extent than the 
peak Ic,. The anti-peptide antibodies and the w-Aga-IVA, on 
the other hand, were equally effective as inhibitors of peak and 
plateau IcB (see Figs. 5, 6). When these experiments were carried 
out from a holding potential of -40 mV instead of -80 mV, 
the antibodies were similarly effective, inhibiting the peak Z,, 
by 70 + 9% (n = 16 cells) and the plateau Zc. by 78 + 8% (n 
= 16 cells) (not shown). This observation agrees with published 
reports that P-type channels are functional with a more depo- 
larized holding potential (Regan et al., 199 1). In conclusion, 
these results demonstrate that the anti-peptide antibodies act 
on a component of the current that remains after application of 
nifedipine and w-CgTx-GVIA. 
Discussion 
In the present study we describe the presence of a P-type VGCC 
01, subunit in SCLC cells. We have isolated from human H146 
SCLC cells a partial cDNA clone (SCLC-P) that is highly ho- 
mologous to putative P-type VGCC (Y, subunits cloned from 
rabbit (Mori et al., 199 1) and rat (Starr et al., 199 1) brain. 
Antibodies raised to a unique acidic peptide encoded by this 
cDNA clone inhibited calcium current induced by depolarizing 
potentials in SCLC cells. Current models of VGCC membrane 
topology suggest that relatively little of the (Y, subunit is exposed 
on the extracellular surface ofthe membrane. The acidic peptide 
against which our antibodies were generated is predicted to be 
located near the extracellular entrance to the channel pore just 
upstream of the SS 1 and SS2 membrane-spanning domains (HS 
segment) that are thought to line the pore of the channel, as 
evidenced by mutational analysis of the corresponding regions 
in sodium and potassium channels (Yellen et al., 1991; Hei- 
nemann et al., 1992) and, more recently, in a calcium channel 
(Tang et al., 1993). Our data support a model in which this 
region is exposed at the extracellular surface because the anti- 
peptide antibodies bind extracellularly and interfere with cal- 
cium currents. 
We have also shown that the P-type-specific toxin w-Aga- 
IVA inhibits calcium currents in SCLC cells. It is worth noting 
that while the antibodies block approximately 20% of the cal- 
cium current, w-Aga-IVA blocks a larger percentage, approxi- 
mately 28%. However, the mechanism of the inhibitory effect 
of the antibody is not known; it could result either from the 
obstruction of the open channel or by preventing the channel 
from achieving an open conformation. Thus, there is no reason 
to expect complete inhibition ofchannel activity by the antibody 
because, for example, it may only partially occlude the channel 
pore. It could be that the agatoxin provides a more complete 
block of channel function. Another possibility is that the anti- 
body inhibits only a subclass of P-type channels while the toxin 
inhibits additional channels. Notably, the nonadditivity of the 
inhibitory effects of toxin and anti-peptide antibodies is con- 
sistent with their action on the same type of channel. While 
apparent differences in the functional properties of a putative 
P-type transcript (BI) expressed in Xenopus oocytes and P-type 
calcium channels characterized in native tissues have been de- 
scribed (Sather et al., 1993) these differences may be attribut- 
able to the expression system. Our results characterizing native 
expression in SCLC cells support the hypothesis that the SCLC-P 
transcript encodes a P-type channel. 
Neither the anti-peptide antibodies nor the w-Aga-IVA cause 
a complete block of calcium currents because SCLC cells have 
multiple types of VGCCs. In addition to the SCLC-P clone 
described here, we have isolated partial cDNAs corresponding 
to the a!, subunit of L-type VGCCs from H 146 SCLC cells (Barry 
and Froehner, 199 1). The presence of L-type VGCCs is consis- 
tent with the known inhibitory effects of DHP antagonists on 
calcium currents (Pancrazio et al., 1992). Our anti-peptide an- 
tibodies inhibit a component of the calcium current that is not 
blocked by application of inhibitors of L-type and N-type cal- 
cium channels (nifedipine and w-CgTx-GVIA, respectively). This 
data demonstrates the specificity of the antibodies for P-type 
calcium channels. It is interesting that even in the presence of 
anti-peptide antibodies, nifedipine, and w-CgTx-GVIA, some 
calcium current remains in these cells. Similar resistant currents 
have been reported in neuronal cells (Mintz et al., 1992a). 
A presynaptic calcium channel that regulates cholinergic 
transmitter release from the mammalian motor nerve terminal 
is thought to be the target of autoantibodies in the neuromus- 
cular disease LES, which is commonly associated with SCLC 
(Vincent et al., 1989). Although it is not known which type of 
VGCC is the relevant target for LES autoantibodies, several 
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studies have provided evidence for binding of LES antibodies 
to either N-type or L-type VGCCs. LES IgG immunoprecipi- 
tates w-CgTx-GVIA receptor complexes implicating N-type 
channels (Sher et al., 1989, 1990; Leys et al., 199 1). The results 
of patch-clamp experiments suggest inhibition of L-type VGCCs 
by LES antibodies (Peers et al., 1990). However, the release of 
acetylcholine at the mammalian neuromuscular junction is not 
inhibited by w-CgTx-GVIA (Olivera et al., 1985; Sano et al., 
1987; Du Luca et al., 199 1; Protti et al., 1991) or DHPs (At- 
chison, 1989; Burges and Wray, 1989). On the other hand, the 
release ofacetylcholine is inhibited by FTX (Uchitel et al., 1992) 
and w-Aga-IVA (Kim et al., 1993) implicating P-type channels 
in this process. Thus, the P-type calcium channel that we de- 
scribe in SCLC cells may be a candidate for an SCLC antigen 
involved in the induction of LES. Evidence in our preliminary 
experiments (Viglione and Kim, 1993) demonstrating that LES 
IgG indeed downregulates the P-type calcium channel in SCLC 
cells is consistent with this proposal. It may now be possible to 
test the role of P-type channels in LES by injecting animals with 
either a fusion protein containing the SCLC-P clone or with the 
acidic peptide itself and examining the animals for the devel- 
opment of LES symptoms. Immunoreactivity of LES sera with 
two calcium channel-associated proteins, the P-subunit (Ro- 
senfeld et al., 1993) and synaptotagmin (Leveque et al., 1992), 
has been reported. Therefore, it is worth considering that LES 
autoantibodies may cross-react with several different types of 
VGCCs due to the presence of homologous epitopes on their LYE 
subunits or to the sharing of accessory subunits or other asso- 
ciated proteins. 
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